Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease

PURPOSE: To evaluate the efficacy of one intravitreal injection of dexamethasone (Ozurdex(®); Allergan, Inc., Irvine, Calif., USA) in serous macular detachment (SMD) of one eye, associated with bilateral central retinal vein occlusion (CRVO) in a patient affected by Waldenström's macroglobuline...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fenicia, Vito, Balestrieri, Marco, Perdicchi, Andrea, Maraone, Giorgia, Recupero, Santi Maria
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2013
Matèries:
Published online: July, 2013
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764974/
https://ncbi.nlm.nih.gov/pubmed/24019788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354066
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars